Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer

Journal of Clinical Oncology

Volumn 34, Issue 18, 2016, Pages 2157-2164

  Huang, Yan Qi ^a,b   Liang, Chang Hong ^a,b   He, Lan ^a,c   Tian, Jie ^e   Liang, Cui Shan ^a   Chen, Xin ^d   Ma, Ze Lan ^a,b   Liu, Zai Yi ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

^e INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; CALIBRATION; CANCER GRADING; CANCER PROGNOSIS; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; IMAGE PROCESSING; INSTRUMENT VALIDATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RDIOMICS NOMOGRAM; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY; BLOOD; COLORECTAL TUMOR; DIAGNOSTIC IMAGING; MIDDLE AGED; PATHOLOGY; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NOMOGRAMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84973651850     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.65.9128     Document Type: Article

References (40)

1. Ferlay J, Shin HR, Bray F, et al: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917, 2010
2. Ferlay J, Soerjomataram I, Dikshit R, et al: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359-E386, 2015
3. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al: Lymph node evaluation and survival after curative resection of colon cancer: Systematic review. J Natl Cancer Inst 99:433-441, 2007
4. Engstrom PF, Arnoletti JP, Benson AB III, et al: NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw 7:778-831, 2009
5. Glasgow SC, Bleier JI, Burgart LJ, et al: Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases. J Gastrointest Surg 16:1019-1028, 2012
6. Smith AJ, Driman DK, Spithoff K, et al: Guideline for optimization of colorectal cancer surgery and pathology. J Surg Oncol 101:5-12, 2010
7. Toiyama Y, Inoue Y, Shimura T, et al: Serum angiopoietin-like protein 2 improves preoperative detection of lymph node metastasis in colorectal cancer. Anticancer Res 35:2849-2856, 2015
8. Barton JB, Langdale LA, Cummins JS, et al: The utility of routine preoperative computed tomography scanning in the management of veterans with colon cancer. Am J Surg 183:499-503, 2002
9. Leufkens AM, van den Bosch MA, van Leeuwen MS, et al: Diagnostic accuracy of computed tomography for colon cancer staging: A systematic review. Scand J Gastroenterol 46:887-894, 2011
10. Otchy D, Hyman NH, Simmang C, et al: Practice parameters for colon cancer. Dis Colon Rectum 47:1269-1284, 2004
11. Dighe S, Purkayastha S, Swift I, et al: Diagnostic precision of CT in local staging of colon cancers: A meta-analysis. Clin Radiol 65:708-719, 2010
12. Aerts HJ, Velazquez ER, Leijenaar RT, et al: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006, 2014 [Erratum: Nat Commun 5:4644, 2014]
13. Gillies RJ, Kinahan PE, Hricak H: Radiomics: Images are more than pictures, they are data. Radiology 278:563-577, 2016
14. Kuo MD, Gollub J, Sirlin CB, et al: Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. J Vasc Interv Radiol 18:821-831, 2007
15. Lambin P, Rios-Velazquez E, Leijenaar R, et al: Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441-446, 2012
16. Kuo MD, Jamshidi N: Behind the numbers: Decoding molecular phenotypes with radiogenomics-Guiding principles and technical considerations. Radiology 270:320-325, 2014
17. Gevaert O, Xu J, Hoang CD, et al: Non-small cell lung cancer: Identifying prognostic imaging biomarkers by leveraging public gene expression microarray data - Methods and preliminary results. Radiology 264:387-396, 2012
18. Mazurowski MA: Radiogenomics: What it is and why it is important. J Am Coll Radiol 12:862-866, 2015
19. Birkhahn M, Mitra AP, Cote RJ: Molecular markers for bladder cancer: The road to a multimarker approach. Expert Rev Anticancer Ther 7:1717-1727, 2007
20. Croner RS, Förtsch T, Brückl WM, et al: Molecular signature for lymphatic metastasis in colorectal carcinomas. Ann Surg 247:803-810, 2008
21. Miles KA, Ganeshan B, Griffiths MR, et al: Colorectal cancer: Texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology 250:444-452, 2009
22. Ng F, Ganeshan B, Kozarski R, et al: Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: Contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 266:177-184, 2013
23. Sauerbrei W, Royston P, Binder H: Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med 26:5512-5528, 2007
24. Collins GS, Reitsma JB, Altman DG, et al: Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. BMJ 350:g7594, 2015
25. Sauerbrei W, Boulesteix AL, Binder H: Stability investigations of multivariable regression models derived from low- and high-dimensional data. J Biopharm Stat 21:1206-1231, 2011
26. Kramer AA, Zimmerman JE: Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited. Crit Care Med 35:2052-2056, 2007
27. Pencina MJ, D'Agostino RB Sr, Steyerberg EW: Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30:11-21, 2011
28. Tangri N, Stevens LA, Griffith J, et al: A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305:1553-1559, 2011
29. Vickers AJ, Cronin AM, Elkin EB, et al: Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak 8:53, 2008
30. Harrell FE Jr: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY, Springer, 2015
31. Gorelik E, Landsittel DP, Marrangoni AM, et al: Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Biomarkers Prev 14:981-987, 2005
32. Paik S, Shak S, Tang G, et al: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817-2826, 2004
33. Sparano JA, Gray RJ, Makower DF, et al: Prospective validation of a 21-gene expression assay in breast cancer. N Engl J Med 373:2005-2014, 2015
34. Compton C, Fenoglio-Preiser CM, Pettigrew N, et al: American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 88:1739-1757, 2000
35. Duffy MJ: Carcinoembryonic antigen as a marker for colorectal cancer: Is it clinically useful? Clin Chem 47:624-630, 2001
36. Thirunavukarasu P, Talati C, Munjal S, et al: Effect of incorporation of pretreatment serum carcinoembryonic antigen levels into AJCC staging for colon cancer on 5-year survival. JAMA Surg 150:747-755, 2015
37. Balachandran VP, Gonen M, Smith JJ, et al: Nomograms in oncology: More than meets the eye. Lancet Oncol 16:e173-e180, 2015
38. Localio AR, Goodman S: Beyond the usual prediction accuracy metrics: Reporting results for clinical decision making. Ann Intern Med 157:294-295, 2012
39. Van Calster B, Vickers AJ: Calibration of risk prediction models: Impact on decision-analytic performance. Med Decis Making 35:162-169, 2015
40. Nakarai C, Osawa K, Akiyama M, et al: Expression of AKR1C3 and CNN3 as markers for detection of lymph node metastases in colorectal cancer. Clin Exp Med 15:333-341, 2015